Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK11

RBC: NEK11 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dabrafenib92.10.63
Vemurafenib64.00.60
Dasatinib47.00.70
Repotrectinib45.40.61
Fedratinib22.80.58
Pexidartinib22.60.63
Asciminib19.70.60
Futibatinib16.50.72
Crizotinib14.50.58
Darovasertib14.10.72
Quizartinib13.80.74
Sirolimus12.30.71
Umbralisib12.00.67
Lapatinib11.90.62
Pacritinib11.50.45

Known variants

No variants catalogued.
Open in new tab